Trial Profile
Phase I Clinical Trial of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Pemetrexed and Cisplatin in Patients With Advanced Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary) ; Vorinostat (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme
- 30 Jul 2008 Status changed from in progress to completed, as reported on clinicaltrials.gov
- 08 Feb 2008 Status change from recruiting to in progress.
- 14 Nov 2007 Trial centre added.